Environmental Methicillin-resistant Staphylococcus aureus Contamination, Persistent Colonization, and Subsequent Skin and Soft Tissue Infection.
Adolescent
Adult
Aged
Aged, 80 and over
Animals
Child
Child, Preschool
Community-Acquired Infections
/ microbiology
Family Characteristics
Female
Humans
Infant
Male
Methicillin-Resistant Staphylococcus aureus
/ isolation & purification
Middle Aged
Missouri
Pets
Prospective Studies
Recurrence
Risk Factors
Skin Diseases, Bacterial
/ microbiology
Soft Tissue Infections
/ microbiology
Staphylococcal Infections
/ microbiology
Journal
JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
pubmed:
1
4
2020
medline:
23
3
2021
entrez:
1
4
2020
Statut:
ppublish
Résumé
The longitudinal association among persistent Staphylococcus aureus colonization, household environmental contamination, and recurrent skin and soft tissue infection (SSTI) is largely unexplored to date. To identify factors associated with persistent S aureus colonization and recurrent SSTI in households with children with community-associated methicillin-resistant S aureus (MRSA) SSTI. This 12-month prospective cohort study included 150 children with community-associated MRSA SSTI, 542 household contacts, and 154 pets enrolled from January 3, 2012, through October 20, 2015. A total of 5 quarterly home visits were made to 150 households in the St Louis, Missouri, region. Statistical analysis was performed from September 18, 2018, to January 7, 2020. Covariates used in S aureus strain persistence and interval SSTI models included S aureus colonization and contamination measures, personal hygiene and sharing habits, health history, activities external to the home, and household characteristics (eg, cleanliness, crowding, home ownership, and pets). Serial samples to detect S aureus were collected from household members at 3 anatomic sites, from pets at 2 anatomic sites, and from environmental surfaces at 21 sites. Molecular epidemiologic findings of S aureus isolates were assessed via repetitive-sequence polymerase chain reaction. Individual persistent colonization was defined as colonization by an identical strain for 2 consecutive samplings. Longitudinal, multivariable generalized mixed-effects logistic regression models were used to assess factors associated with persistent S aureus personal colonization, environmental contamination, and interval SSTI. Among 692 household members in 150 households, 326 (47%) were male and 366 (53%) were female, with a median age of 14.82 years (range, 0.05-82.25 years). Of 540 participants completing all 5 samplings, 213 (39%) were persistently colonized with S aureus, most often in the nares and with the strain infecting the index patient at enrollment. Nine pets (8%) were persistently colonized with S aureus. Participants reporting interval intranasal mupirocin application were less likely to experience persistent colonization (odds ratio [OR], 0.44; 95% credible interval [CrI], 0.30-0.66), whereas increasing strain-specific environmental contamination pressure was associated with increased individual persistent colonization (OR, 1.17; 95% CrI, 1.06-1.30). Strains with higher colonization pressure (OR, 1.47; 95% CrI, 1.25-1.71) and MRSA strains (OR, 1.57; 95% CrI, 1.16-2.19) were more likely to persist. Seventy-six index patients (53%) and 101 household contacts (19%) reported interval SSTIs. Individuals persistently colonized with MRSA (OR, 1.56; 95% CrI, 1.17-2.11), those with a history of SSTI (OR, 2.55; 95% CrI, 1.88-3.47), and index patients (OR, 1.54; 95% CrI, 1.07-2.23) were more likely to report an interval SSTI. The study findings suggest that recurrent SSTI is associated with persistent MRSA colonization of household members and contamination of environmental surfaces. Future studies may elucidate the effectiveness of specific combinations of personal decolonization and environmental decontamination efforts in eradicating persistent strains and mitigating recurrent SSTIs.
Identifiants
pubmed: 32227144
pii: 2763351
doi: 10.1001/jamapediatrics.2020.0132
pmc: PMC7105954
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
552-562Subventions
Organisme : NIAID NIH HHS
ID : K23 AI091690
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI097434
Pays : United States
Organisme : AHRQ HHS
ID : R01 HS024269
Pays : United States
Organisme : AHRQ HHS
ID : R01 HS021736
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Références
Lancet Infect Dis. 2020 Feb;20(2):188-198
pubmed: 31784369
J Transl Med. 2014 May 12;12:124
pubmed: 24886400
JAMA Pediatr. 2014 Nov;168(11):1030-8
pubmed: 25200331
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Pediatrics. 2016 Apr;137(4):
pubmed: 26933211
Medicine (Baltimore). 2015 Sep;94(37):e1534
pubmed: 26376402
Clin Infect Dis. 2015 Mar 1;60(5):753-63
pubmed: 25428411
Infect Control Hosp Epidemiol. 2011 Sep;32(9):872-80
pubmed: 21828967
Clin Infect Dis. 2012 Jun;54(11):1523-35
pubmed: 22474221
J Infect. 2019 Mar;78(3):200-207
pubmed: 30503843
Clin Infect Dis. 2014 Mar;58(5):679-82
pubmed: 24265356
Ann Public Health Res. 2015 Jan 29;2(1):
pubmed: 25893222
Infect Control Hosp Epidemiol. 2015 Jul;36(7):786-93
pubmed: 25869756
J Pediatr. 2014 Jan;164(1):105-11
pubmed: 24128648
Int Psychogeriatr. 2009 Dec;21(6):1041-50
pubmed: 19589191
Pediatr Res. 2018 Nov;84(5):668-676
pubmed: 30135590
Semin Pediatr Infect Dis. 2006 Jul;17(3):113-9
pubmed: 16934705
Infect Control Hosp Epidemiol. 2017 Jan;38(1):61-67
pubmed: 27821194
Clin Infect Dis. 2008 Mar 1;46(5):752-60
pubmed: 18220477
Infect Control Hosp Epidemiol. 2014 Nov;35(11):1373-82
pubmed: 25333432
Future Microbiol. 2007 Oct;2(5):457-9
pubmed: 17927464
J Pediatric Infect Dis Soc. 2013 Jun;2(2):147-54
pubmed: 23717786
PLoS One. 2013;8(1):e52722
pubmed: 23300988
Pediatr Infect Dis J. 2011 Nov;30(11):927-32
pubmed: 21617572
Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):551-7
pubmed: 22665030
Clin Infect Dis. 2012 Mar;54(6):743-51
pubmed: 22198793
Clin Infect Dis. 2004 Sep 15;39(6):806-11
pubmed: 15472812
R Soc Open Sci. 2018 Feb 14;5(2):172341
pubmed: 29515909
Infect Genet Evol. 2014 Jan;21:531-41
pubmed: 23619097
J Clin Microbiol. 1995 Aug;33(8):2141-4
pubmed: 7559964
Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8
pubmed: 17682105
Clin Infect Dis. 2015 May 15;60(10):1489-96
pubmed: 25648237
J Infect. 2009 Dec;59(6):394-401
pubmed: 19747505
JAMA Intern Med. 2016 Jun 1;176(6):807-15
pubmed: 27159126